pharmacy benefit managers (PBMs) News

How to Keep Big Pharma from Winning Drug Price Wars: Joe Nocera

Robin Feldman is a law professor at the University of California Hastings with a particular expertise in antitrust and patent issues. She is also one of those professors who are unusually good at explaining complex issues in terms laymen (like …

Kentucky Investigating Drug Overcharges by Pharmacy Benefit Managers

Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that pharmacy benefit managers (PBMs) had overcharged state health insurance programs for drugs and discriminated against independent pharmacies. The investigation comes against the backdrop of …

Cigna CEO Says Ending Benefits Manager Rebates Won’t Harm Commercial Market

The U.S. government’s proposal to eliminate rebates that pharmacy benefit managers receive from drugmakers will not have a meaningful impact on growth, and does not affect the commercial market, Cigna Corp. Chief Executive Officer David Cordani said on Friday. Investors …

Cigna Completes $54 Billion Acquisition of Express Scripts

Cigna Corp. on Thursday closed its $54-billion deal to buy Express Scripts Holding Co., creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination …

CVS Says It Closed on Deal to Buy Aetna But Judge Balks

In an unusual move on Thursday, a federal judge raised the prospect of not approving CVS Health Corp.’s deal to buy insurer Aetna Inc., which closed earlier this week, during a routine portion of the legal process. Judge Richard Leon …

CVS Acquisition of Aetna Expected to Close After Thanksgiving

CVS Health Corp. said on Tuesday that it expects to close its $69 billion purchase of health insurer Aetna Inc. after the Thanksgiving holiday. The pharmacy chain and benefits manager had previously expected the transaction to close by Nov. 22. …

On the Side, Express Scripts Eyes Distributing High-Priced Specialty Drugs

Express Scripts Holding Co. built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs. Express …

Icahn Warns Cigna Shareholders to Vote Against ‘Overpriced’ Express Scripts Deal

Activist investor Carl Icahn said shareholders in Cigna Corp. should vote against the $54 billion takeover of pharmacy-benefits firm Express Scripts Holding Co. because the health insurer is “dramatically overpaying.” “Cigna management is offering to pay an all-time high price …

Cigna Confident About Express Scripts Deal, Despite Icahn Opposition

Cigna Corp. said on Thursday it was confident of winning shareholder approval for its $52 billion Express Scripts buyout, a day after reports that investor Carl Icahn had picked up a stake in the insurer and was planning to vote …

Investor Icahn to Oppose Cigna-Express Deal, Fearing Amazon Threat: Sources

Activist investor Carl Icahn has built a sizable stake in Cigna Corp. and plans to oppose the health insurer’s $54 billion takeover of pharmacy-benefits firm Express Scripts Holding Co., according to people familiar with the matter. Chief among Icahn’s concerns …